Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells
- ChemMedChem. 2011 Apr 4;6(4):606-11. doi: 10.1002/cmdc.201000536.
Affiliations
- 1. Department of Biochemical Sciences, "Sapienza" University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy. [email protected]
PMID: 21365766
DOI: 10.1002/cmdc.201000536
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PARP